SCHEMBL29528262

SCHEMBL29528262

CN1c2ccccc2N(c2c(-c3ccccc3)c(-c3ccccc3)c(-c3nc4cccnc4n3C)c(N3c4ccccc4N(C)c4ccccc43)c2-c2nc3cccnc3n2C)c2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.40
KDM4E B2RXH2 1/20 0.40
CCNB2 O95067 1/20 0.36
CDK1 P06493 1/20 0.36
CCNB1 P14635 1/20 0.36
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36
CCNB3 Q8WWL7 1/20 0.36
ALDH1A1 P00352 2/20 0.36
POLB P06746 1/20 0.36
HSD17B10 Q99714 1/20 0.36
BRD4 O60885 2/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
ATM Q13315 1/20 0.35
RAB9A P51151 2/20 0.34
NPC1 O15118 1/20 0.34
PKM P14618 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ADORA3 P0DMS8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29528081 0.98 MAPT (0.40) MAPTKDM4ECCNB2CDK1CCNB1
SCHEMBL29528480 0.98 MAPT (0.41) MAPTKDM4ECCNB2CDK1CCNB1
SCHEMBL29528719 0.95 MAPT (0.40) MAPTKDM4ECCNB2CDK1CCNB1
SCHEMBL29528266 0.95 MAPT (0.41) MAPTKDM4ECCNB2CDK1CCNB1
SCHEMBL29528308 0.95 MAPT (0.41) MAPTKDM4ECCNB2CDK1CCNB1
SCHEMBL29529047 0.94 MAPT (0.42) MAPTKDM4ECCNB2CDK1CCNB1
SCHEMBL29528549 0.90 MAPT (0.44) MAPTKDM4ECCNB2CDK1CCNB1
SCHEMBL29528681 0.90 MAPT (0.44) MAPTKDM4ECCNB2CDK1CCNB1
SCHEMBL29528541 0.89 MAPT (0.43) MAPTKDM4ECCNB2CDK1CCNB1
SCHEMBL29528804 0.86 MAPT (0.44) MAPTKDM4ECCNB2CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11283027-B1 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2022-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11283027-B1 Composition of matter for use in organic light-emitting diodes ALDH1A2, CYBA, CRY2 MAPT 214/4885KDM4E 4331/4885CCNB2 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.